{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06516913",
            "orgStudyIdInfo": {
                "id": "27209"
            },
            "secondaryIdInfos": [
                {
                    "id": "J3G-MC-S004",
                    "type": "OTHER",
                    "domain": "Eli Lilly and Company"
                }
            ],
            "organization": {
                "fullName": "Eli Lilly and Company",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of Subcutaneous Injection in Healthy Participants",
            "officialTitle": "A Randomized, Participant-Blinded Study to Investigate the Effects of Subcutaneous Injection Volume, Injection Rate, and Needle Length on Pain in Healthy Participants",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-of-subcutaneous-injection-in-healthy-participants"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-07-18",
            "studyFirstSubmitQcDate": "2024-07-18",
            "studyFirstPostDateStruct": {
                "date": "2024-07-24",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-18",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Eli Lilly and Company",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this exploratory study is to learn about the effects of subcutaneous injections on healthy participants.\n\nThe study aims to explore how different delivery methods containing a solution impacts injection pain, without an active drug to complicate the results.\n\nPain assessments will be performed visually and at the injection site to determine the level of pain experienced after each injection.\n\nThis study will last approximately 40 days, including screening, assessment, and follow-up."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 32,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Sequence 1 (ABHCGDFE)",
                    "type": "EXPERIMENTAL",
                    "description": "Syringe pump is used to subcutaneously (SC) administer buffer solution with hyaluronic acid as a viscosity agent",
                    "interventionNames": [
                        "Device: Syringe Pump"
                    ]
                },
                {
                    "label": "Sequence 2 (BCADHEGF)",
                    "type": "EXPERIMENTAL",
                    "description": "Syringe pump is used to SC administer buffer solution with hyaluronic acid as a viscosity agent",
                    "interventionNames": [
                        "Device: Syringe Pump"
                    ]
                },
                {
                    "label": "Sequence 3 (CDBEAFHG)",
                    "type": "EXPERIMENTAL",
                    "description": "Syringe pump is used to SC administer buffer solution with hyaluronic acid as a viscosity agent",
                    "interventionNames": [
                        "Device: Syringe Pump"
                    ]
                },
                {
                    "label": "Sequence 4 (DECFBGAH)",
                    "type": "EXPERIMENTAL",
                    "description": "Syringe pump is used to SC administer buffer solution with hyaluronic acid as a viscosity agent",
                    "interventionNames": [
                        "Device: Syringe Pump"
                    ]
                },
                {
                    "label": "Sequence 5 (EFDGCHBA)",
                    "type": "EXPERIMENTAL",
                    "description": "Syringe pump is used to SC administer buffer solution with hyaluronic acid as a viscosity agent",
                    "interventionNames": [
                        "Device: Syringe Pump"
                    ]
                },
                {
                    "label": "Sequence 6 (FGEHDACB)",
                    "type": "EXPERIMENTAL",
                    "description": "Syringe pump is used to SC administer buffer solution with hyaluronic acid as a viscosity agent",
                    "interventionNames": [
                        "Device: Syringe Pump"
                    ]
                },
                {
                    "label": "Sequence 7 (GHFAEBDC)",
                    "type": "EXPERIMENTAL",
                    "description": "Syringe pump is used to SC administer buffer solution with hyaluronic acid as a viscosity agent",
                    "interventionNames": [
                        "Device: Syringe Pump"
                    ]
                },
                {
                    "label": "Sequence 8 (HAGBFCED)",
                    "type": "EXPERIMENTAL",
                    "description": "Syringe pump is used to SC administer buffer solution with hyaluronic acid as a viscosity agent",
                    "interventionNames": [
                        "Device: Syringe Pump"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Syringe Pump",
                    "description": "Used to administer buffer solution with hyaluronic acid SC",
                    "armGroupLabels": [
                        "Sequence 1 (ABHCGDFE)",
                        "Sequence 2 (BCADHEGF)",
                        "Sequence 3 (CDBEAFHG)",
                        "Sequence 4 (DECFBGAH)",
                        "Sequence 5 (EFDGCHBA)",
                        "Sequence 6 (FGEHDACB)",
                        "Sequence 7 (GHFAEBDC)",
                        "Sequence 8 (HAGBFCED)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Visual analogue scale (VAS) Pain score at Injection Site",
                    "timeFrame": "Needle insertion to 240 minutes"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Are healthy as determined by medical evaluation including medical history and physical examination\n* Have a waist circumference, measured around umbilicus, of at least 78 centimeters (cm) for participants assigned male at birth, and at least 71 cm for participants assigned female at birth\n* Have a BMI within the range of 21.0 to 30.0 kilograms per square meter (kg/m\u00b2)\n* Participants assigned female at birth must be of non-childbearing potential and must test negative for pregnancy prior to injection on Day 1\n\nExclusion Criteria:\n\n* Have known allergies to hyaluronic acid, related compounds, or any components of the formulation, or history of significant atopy. Components of the formulation include, but are not limited to, sodium hyaluronate, sodium chloride, and sodium phosphate\n* Have a history of severe injection-site reactions\n* Have current or previous history of anaphylaxis\n* Have tattoos or scars over the abdomen, or other factors, for example excessive folds of skin, that, in the investigator's opinion, would interfere with injection site assessments\n* Have self-perceived dullness or loss of sensation on either side of the body and the abdomen\n* Have a history or presence of a bleeding, wound healing (including diabetes), or fibrotic disorder\n* Have known or ongoing psychiatric disorders",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "22 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or",
                    "role": "CONTACT",
                    "phone": "1-317-615-4559",
                    "email": "ClinicalTrials.gov@Lilly.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)",
                    "affiliation": "Eli Lilly and Company",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Fortrea CRU, Inc.",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75247",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gene Voskuhl",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M9878",
                    "name": "Hyaluronic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                }
            ]
        }
    },
    "hasResults": false
}